• History of antidiabetic agents 

1.1. Insulin 

1.2. Incretin enhancers (DPP-4 inhibitors, GLP-1 receptor agonists) 

1.3. Metformin 

1.4. SGLT2 inhibitors 

1.5. Thiazolidinediones 

1.6. Sulfonylureas 

• Mechanisms of action - Main characteristics of drugs 

2.1. Incretin enhancers (DPP-4 inhibitors, GLP-1 receptor agonists) 

2.2. Metformin 

2.3. SGLT2 inhibitors 

2.4. Pioglitazone 

2.5. Sulfonylureas 

• Therapeutic algorithm 

3.1. Individuals with a history of myocardial infarction, coronary artery disease 

3.2. Individuals with a history of acute coronary syndrome 

3.3. Individuals with chronic Kidney Disease 

3.4. Elderly individuals - Vulnerable 

3.5. Individuals at risk of hypoglycemia 

3.6. Individuals with heart failure 

• Insulin therapy in type 2 diabetes 

4.1. Types of insulin - Modern classification 

4.2. How to initiate - Which pens are available 

4.3. Intensification of insulin: When, how 

• Treatment of hospitalized patients 

5.1. Introduction 

5.2. Treatment goals for hospitalized diabetic patients 

5.3. Diabetic ketoacidosis and non-ketotic hyperosmolar diabetic coma 

5.4. Management of diabetic patient hospitalized with acute myocardial infarction 

5.5. The diabetic patient in the clinic 

• Examples of patients 
• List of available antidiabetic agents 
• Memo
• Food Groups